Puckrin R, Chua N, Shafey M, Stewart DA, et al. Improving the outcomes of secondary CNS lymphoma with high-dose thiotepa, busulfan, melphalan, rituximab conditioning and autotransplant. Leuk Lymphoma 2022 Apr 22:1-9. doi: 10.1080/10428194.2022.2068005.
PMID: 35459424